Given the variable expression of DiGeorge syndrome (22q11.2 deletion syndrome, or 22q11.2DS) and that complications may occur at different stages in a patient’s life, key features of management include treating manifest complications and undertaking multisystem periodical assessments for anticipated features.[16]Boot E, Óskarsdóttir S, Loo JCY, et al. Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100344.
https://www.gimjournal.org/article/S1098-3600(22)01028-0/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729052?tool=bestpractice.com
[52]Óskarsdóttir S, Boot E, Crowley TB, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100338.
https://www.gimjournal.org/article/S1098-3600(22)01018-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729053?tool=bestpractice.com
[54]Mustillo PJ, Sullivan KE, Chinn IK, et al. Clinical practice guidelines for the immunological management of chromosome 22q11.2 deletion syndrome and other defects in thymic development. J Clin Immunol. 2023 Feb;43(2):247-70.
https://www.doi.org/10.1007/s10875-022-01418-y
http://www.ncbi.nlm.nih.gov/pubmed/36648576?tool=bestpractice.com
Multi-disciplinary care involving consultants and generalists is central to management, as is the involvement of family.
Birth to 4 months
General care and stabilisation
Treatment of infants is characterised by stabilising life-threatening abnormalities and characterising the extent of disease.[52]Óskarsdóttir S, Boot E, Crowley TB, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100338.
https://www.gimjournal.org/article/S1098-3600(22)01018-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729053?tool=bestpractice.com
With congenital heart disease
About 80% of patients with DiGeorge syndrome have congenital heart disease.[48]Marino B, Digilio MC, Toscano A, et al. Anatomic patterns of conotruncal defects associated with deletion 22q11. Genet Med. 2001;3:45-48.
http://www.ncbi.nlm.nih.gov/pubmed/11339377?tool=bestpractice.com
[90]Goldmuntz E. 22q11.2 deletion syndrome and congenital heart disease. Am J Med Genet C Semin Med Genet. 2020 Mar;184(1):64-72.
http://www.ncbi.nlm.nih.gov/pubmed/32049433?tool=bestpractice.com
Conotruncal anomalies such as interrupted aortic arch type B and truncus arteriosus are the most characteristic, but tetralogy of Fallot, ventricular septal defect, and others are also common.[91]Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol. 1998:32;492-98.
https://www.sciencedirect.com/science/article/pii/S0735109798002599?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/9708481?tool=bestpractice.com
[92]Van Mierop LH, Kutsche LM. Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor. Am J Cardiol. 1986;58:133-7.
http://www.ncbi.nlm.nih.gov/pubmed/3728313?tool=bestpractice.com
Cardiac anomalies must be managed as appropriate, and echocardiography performed to define the cardiac anatomy and plan surgical repair.[52]Óskarsdóttir S, Boot E, Crowley TB, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100338.
https://www.gimjournal.org/article/S1098-3600(22)01018-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729053?tool=bestpractice.com
Infants with cardiac disease secondary to DiGeorge syndrome are managed as other infants with the same cardiac anatomy.
For children with congenital heart disease those with 22q11.2 deletion may be more likely to need dialysis post cardiac surgery, and have a greater risk of postoperative infection; but this does not seem to increase mortality or length of intensive care or hospital stay.[93]McDonald R, Dodgen A, Goyal S, et al. Impact of 22q11.2 deletion on the postoperative course of children after cardiac surgery. Pediatr Cardiol. 2013;34:341-7.
http://www.ncbi.nlm.nih.gov/pubmed/22864648?tool=bestpractice.com
With hypocalcaemia
Hypocalcaemia (secondary to hypoparathyroidism) is present in up to 60% of paediatric patients and hypocalcaemic seizures are common in neonates.[59]Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet. 1997;34:798-804.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1051084&blobtype=pdf
http://www.ncbi.nlm.nih.gov/pubmed/9350810?tool=bestpractice.com
[94]Rayannavar A, Levitt Katz LE, Crowley TB, et al. Association of hypocalcemia with congenital heart disease in 22q11.2 deletion syndrome. Am J Med Genet A. 2018 Oct;176(10):2099-103.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6467273
http://www.ncbi.nlm.nih.gov/pubmed/30277015?tool=bestpractice.com
It often becomes less problematic as the child matures.[59]Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet. 1997;34:798-804.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1051084&blobtype=pdf
http://www.ncbi.nlm.nih.gov/pubmed/9350810?tool=bestpractice.com
Hypocalcaemia is managed by calcium and vitamin D (calcitriol) supplementation as necessary.[52]Óskarsdóttir S, Boot E, Crowley TB, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100338.
https://www.gimjournal.org/article/S1098-3600(22)01018-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729053?tool=bestpractice.com
Calcium levels may be corrected orally in most cases, but if there are significant symptoms, such as tetany, seizure, or prolonged QT interval, intravenous correction alongside cardiac monitoring is indicated.
Hypercalciuria is a major complication in the treatment of hypocalcaemia. Calcium and calcitriol must be reduced if hypercalciuria is noted. Hydrochlorothiazide may be added to reduce urine calcium excretion if required.
With palatal abnormalities
At this age, palatal abnormalities should be managed by adaptive feeding approaches in consultation with nutritionists, occupational therapists, feeding specialists, and orthodontists. Options include specialised nipples, prosthetics, and frequent burping. Otitis media and airway obstruction occur commonly with clefts and should be evaluated. Surgery is an option if other measures are not successful or in the case of overt cleft palates.[52]Óskarsdóttir S, Boot E, Crowley TB, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100338.
https://www.gimjournal.org/article/S1098-3600(22)01018-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729053?tool=bestpractice.com
Growth parameters should be carefully monitored, particularly to allow for early detection of feeding difficulties.
With feeding difficulty
With thyroid dysfunction
With renal obstruction or hypoplasia
Infants and toddlers (4 months to 5 years)
Many in this age range still require further repair of their cardiac defects. Infants with hypocalcaemia should continue to receive calcium and calcitriol supplementation. Therapy is continued as needed for hypothyroidism.
With palatal abnormalities
Surgical repair is required for frank clefts and submucous clefts.[52]Óskarsdóttir S, Boot E, Crowley TB, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100338.
https://www.gimjournal.org/article/S1098-3600(22)01018-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729053?tool=bestpractice.com
Patients who have only palatal insufficiency may not need surgical correction, although if speech therapy fails to adequately improve diction and intelligibility, there are surgical options to improve this.
With feeding difficulty
Children in this age group routinely have feeding difficulties that may or may not be associated with cleft palate. The first-line therapy is modified feeding approaches to ease feeding, including changing nipples, using bottle feeding if breastfeeding is inadequate, thickening feeds, or changing formulas.
Second-line therapy may be required and usually involves placing a percutaneous gastrostomy tube. This should be considered if the child does not gain weight despite other feeding interventions. Feeding difficulties can easily persist for months to years, but generally resolve before school age.
With delayed speech acquisition
In older toddlers, delayed acquisition of speech is a characteristic feature.[52]Óskarsdóttir S, Boot E, Crowley TB, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100338.
https://www.gimjournal.org/article/S1098-3600(22)01018-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729053?tool=bestpractice.com
This is not due solely to palate defects, but occurs in most children. This should be treated with speech therapy early and use of bridging sign language. Specific recommendations are available for the management of speech therapy in DiGeorge Syndrome.[44]Solot CB, Sell D, Mayne A, et al. Speech-language disorders in 22q11.2 deletion syndrome: best practices for diagnosis and management. Am J Speech Lang Pathol. 2019 Aug 9;28(3):984-99.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802924
http://www.ncbi.nlm.nih.gov/pubmed/31330115?tool=bestpractice.com
For those with velopharyngeal insufficiency, surgical repair may be indicated to improve speech outcomes.[95]Filip C, Matzen M, Aukner R, et al. Superiorly based pharyngeal flap for treatment of velopharyngeal insufficiency in patients with 22q11.2 deletion syndrome. J Craniofac Surg. 2013;24:501-4.
http://www.ncbi.nlm.nih.gov/pubmed/23524725?tool=bestpractice.com
With immunodeficiency
Patients with demonstrated immune dysfunction should be referred to an immunologist. Those with mild to moderate immunodeficiency should be monitored for the presence of infection. Those with significant T-cell deficiency (marked T-cell lymphopenia and absent proliferative responses) should be given trimethoprim/sulfamethoxazole prophylaxis and intravenous immunoglobulin, prepared for thymic transplant, or have adoptive transfer of mature T cells arranged.[17]Land MH, Garcia-Lloret MI, Borzy MS, et al. Long-term results of bone marrow transplantation in complete DiGeorge syndrome. J Allergy Clin Immunol. 2007;120:908-15.
http://www.ncbi.nlm.nih.gov/pubmed/17931564?tool=bestpractice.com
[96]Markert ML, Boeck A, Hale LP, et al. Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med. 1999;341:1180-9.
https://www.nejm.org/doi/10.1056/NEJM199910143411603
http://www.ncbi.nlm.nih.gov/pubmed/10523153?tool=bestpractice.com
Infants should be monitored for the development of oligoclonal T-cell populations with frequent flow cytometric T-cell counts. Infants with significant T-cell immunodeficiency (<600 T cells/mm^3) should receive no live virus vaccines and should receive only irradiated, filtered (leukodepleted) blood products.[97]Moylett EH, Wasan AN, Noroski LM, et al. Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity. Clin Immunol. 2004;112:106-112.
http://www.ncbi.nlm.nih.gov/pubmed/15207787?tool=bestpractice.com
[98]Perez EE, Bokszczanin A, McDonald-McGinn D, et al. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Pediatrics. 2003;112:e325.
http://pediatrics.aappublications.org/cgi/content/full/112/4/e325
http://www.ncbi.nlm.nih.gov/pubmed/14523220?tool=bestpractice.com
[99]Chinen J, Rosenblatt HM, Smith EO, et al. Long-term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol. 2003;111:573-579.
http://www.ncbi.nlm.nih.gov/pubmed/12642839?tool=bestpractice.com
[100]Davis CM, Kancherla VS, Reddy A, et al. Development of specific T-cell responses to Candida and tetanus antigens in partial DiGeorge syndrome. J Allergy Clin Immunol. 2008;122:1194-1199.
http://www.ncbi.nlm.nih.gov/pubmed/18789819?tool=bestpractice.com
[101]Azzari C, Gamineri E, Resti M, et al. Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome). Vaccine. 2005;23:1668-1671.
http://www.ncbi.nlm.nih.gov/pubmed/15705470?tool=bestpractice.com
[102]Sullivan KE. Live viral vaccines in patients with DiGeorge syndrome. Clin Immunol. 2004;113:3.
http://www.ncbi.nlm.nih.gov/pubmed/15380522?tool=bestpractice.com
[103]Waters V, Peterson KS, LaRussa P. Live viral vaccines in a DiGeorge syndrome patient. Arch Dis Child. 2007;92:519-520.
http://www.ncbi.nlm.nih.gov/pubmed/16798784?tool=bestpractice.com
With sinopulmonary infections
Sinopulmonary infection and viral infection incidences are increased in this population and occur regardless of detectable immunodeficiency.[42]Biggs SE, Gilchrist B, May KR. Chromosome 22q11.2 deletion (DiGeorge syndrome): immunologic features, diagnosis, and management. Curr Allergy Asthma Rep. 2023 Apr;23(4):213-22.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9999075
http://www.ncbi.nlm.nih.gov/pubmed/36897497?tool=bestpractice.com
[68]Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007;370:1443-52.
http://www.ncbi.nlm.nih.gov/pubmed/17950858?tool=bestpractice.com
Bacterial infections should be managed with targeted antibiotic therapy.
School age (5 years to 18 years)
By school age, most feeding issues have improved. The primary issues in this age range are learning disorders and behavioural problems.[52]Óskarsdóttir S, Boot E, Crowley TB, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100338.
https://www.gimjournal.org/article/S1098-3600(22)01018-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729053?tool=bestpractice.com
Monitoring and treatment of sinopulmonary infections is important. Therapy is continued as needed for hypothyroidism or hypoparathyroidism. Patients with congenital heart disease and palatal abnormalities may need continued follow-up.
With learning disorders and behavioural problems
DiGeorge syndrome children may be shy, withdrawn, or anxious. Rates of attention-deficit/hyperactivity disorder, oppositional defiant disorder, and autistic spectrum disorders are higher than in the general population.[104]Antshel KM, Fremont W, Roizen NJ, et al. ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry. 2006;45:596-603.
http://www.ncbi.nlm.nih.gov/pubmed/16670654?tool=bestpractice.com
The initial approach should involve standard behavioural modification techniques. Management of these symptoms may require consultation with developmental paediatricians and psychiatrists.
Although children have speech delay, their language abilities are relatively preserved later in life when non-verbal learning disorders become predominant. Maths skills may be weak. These aspects should be approached with an individualised education plan.
Adults
Regardless of age at diagnosis, follow-up in adults with DiGeorge syndrome is required. Congenital or early-onset features also require frequent monitoring and management as appropriate.[16]Boot E, Óskarsdóttir S, Loo JCY, et al. Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100344.
https://www.gimjournal.org/article/S1098-3600(22)01028-0/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729052?tool=bestpractice.com
Increased risk for sinopulmonary infections persists, and infections should be treated aggressively with appropriate antibiotic therapy. Therapy is continued as needed for hypothyroidism or hypoparathyroidism. Patients with congenital heart disease may continue to need follow-up into adulthood.
With psychiatric disorders
Psychiatric disorders comprise the majority of late-onset features.[45]Biswas AB, Furniss F. Cognitive phenotype and psychiatric disorder in 22q11.2 deletion syndrome: a review. Res Dev Disabil. 2016 Jun-Jul;53-54:242-57.
http://www.ncbi.nlm.nih.gov/pubmed/26942704?tool=bestpractice.com
Psychiatrists should manage patients with psychosis or schizophrenia with appropriate antipsychotic therapy. Depression, anxiety disorders, and bipolar disorder also occur and are managed as for patients without DiGeorge syndrome.[16]Boot E, Óskarsdóttir S, Loo JCY, et al. Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome. Genet Med. 2023 Mar;25(3):100344.
https://www.gimjournal.org/article/S1098-3600(22)01028-0/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36729052?tool=bestpractice.com
Therapy of schizophrenia is generally typical, but resistance to antipsychotic therapy may be more of an issue. There are few published data on therapeutic recommendations for patients with DiGeorge syndrome, but one case report has successfully used aripiprazole for treatment of resistant psychosis, while another successfully used quetiapine.
If hypocalcaemia is present it should be corrected, as hypocalcaemia alone may provoke psychosis.[105]Lin CE, Hwang KS, Hsieh PH, et al. Treatment of schizophreniform disorder by aripiprazole in a female adolescent with 22q11.2 deletion syndrome. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1141-3.